Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+36.4%
5Y CAGR+38.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+36.4%/yr
vs +14.6%/yr prior
5Y CAGR
+38.6%/yr
Consistent
Acceleration
+21.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $87.25M | +26.7% |
| 2024 | $68.84M | +32.5% |
| 2023 | $51.97M | +51.1% |
| 2022 | $34.39M | +57.2% |
| 2021 | $21.88M | +28.4% |
| 2020 | $17.04M | +15.4% |
| 2019 | $14.76M | -25.9% |
| 2018 | $19.92M | +43497.4% |
| 2017 | $45689.00 | +5.3% |
| 2016 | $43406.00 | - |